[1]
S. Demir and A. Özkan, “Vortioxetine modulates Nrf2/HO-1 signaling and antioxidant defense in a cuprizone-induced demyelination model”, Exp Biomed Res, vol. 8, no. 3, pp. 149–160, Jul. 2025.